Diaceutics PLC (AIM:DXRX)

Market Cap	147.30M +47.1%
Revenue (ttm)	34.40M +31.8%
Net Income	-1.52M
EPS	-0.02
Shares Out	84.65M
PE Ratio	n/a
Forward PE	280.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,029
Average Volume	228,392
Open	173.00
Previous Close	174.00
Day's Range	173.00 - 180.00
52-Week Range	112.25 - 178.00
Beta	0.92
RSI	70.29
Earnings Date	May 27, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 213
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DXRX

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.